Dr. Reddy's Laboratories Share Price
- Advice
- Hold
Start SIP in Dr. Reddy's Laboratories
Start SIPDr. Reddy's Laboratories Performance
Day Range
- Low 6,603
- High 6,666
52 Week Range
- Low 5,206
- High 7,107
- Open Price6,640
- Previous Close6,647
- Volume182347
Dr. Reddy's Laboratories F&O
Dr. Reddy's Laboratories Investment Rating
-
Master Rating:
-
Dr. Reddy's Laboratories has an operating revenue of Rs. 28,949.30 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 26% is great, ROE of 19% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 5,841 | 5,082 | 4,103 | 4,839 | 5,437 | 4,249 |
Operating Expenses Qtr Cr | 3,888 | 3,700 | 3,447 | 3,210 | 3,210 | 3,489 |
Operating Profit Qtr Cr | 1,953 | 1,379 | 656 | 1,629 | 2,228 | 1,061 |
Depreciation Qtr Cr | 250 | 246 | 246 | 246 | 237 | 237 |
Interest Qtr Cr | 7 | 6 | 6 | 6 | 5 | 3 |
Tax Qtr Cr | 497 | 304 | 157 | 408 | 580 | 264 |
Net Profit Qtr Cr | 1,417 | 1,035 | 475 | 1,193 | 1,639 | 672 |
Dr. Reddy's Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹6,751.08
- 50 Day
- ₹6,705.82
- 100 Day
- ₹6,526.91
- 200 Day
- ₹6,233.70
- 20 Day
- ₹6,813.61
- 50 Day
- ₹6,805.58
- 100 Day
- ₹6,429.26
- 200 Day
- ₹6,215.43
Dr. Reddy's Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 6,663.93 |
Second Resistance | 6,696.22 |
Third Resistance | 6,726.68 |
RSI | 39.98 |
MFI | 28.02 |
MACD Single Line | -23.64 |
MACD | -52.60 |
Support | |
---|---|
First Support | 6,601.18 |
Second Support | 6,570.72 |
Third Supoort | 6,538.43 |
Dr. Reddy's Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 189,238 | 11,645,707 | 61.54 |
Week | 298,129 | 16,909,900 | 56.72 |
1 Month | 343,345 | 20,291,668 | 59.1 |
6 Month | 448,415 | 24,662,849 | 55 |
Dr. Reddy's Laboratories Result Highlights
Dr. Reddy's Laboratories Synopsis
NSE-Medical-Diversified
Dr. Reddy's Labs is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 19483.80 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2024. Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507.Market Cap | 110,920 |
Sales | 19,888 |
Shares in Float | 12.18 |
No of funds | 930 |
Yield | 0.6 |
Book Value | 4.57 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | |
Alpha | 0.02 |
Beta | 0.37 |
Dr. Reddy's Laboratories Shareholding Pattern
Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 26.65% | 26.65% | 26.65% | 26.66% |
Mutual Funds | 10.05% | 7.96% | 8.22% | 8.61% |
Insurance Companies | 7.88% | 7.72% | 7.94% | 10.14% |
Foreign Portfolio Investors | 27.68% | 29.13% | 28.62% | 28.19% |
Financial Institutions/ Banks | 0.11% | 0.07% | 0.05% | |
Individual Investors | 8.07% | 8.25% | 8.44% | 7.91% |
Others | 19.56% | 20.22% | 20.08% | 18.49% |
Dr. Reddy's Laboratories Management
Name | Designation |
---|---|
Mr. K Satish Reddy | Chairman |
Mr. G V Prasad | Co-Chairman & Manag. Director |
Dr. Claudio Albrecht | Independent Director |
Ms. Kalpana Morparia | Independent Director |
Mr. Leo Puri | Independent Director |
Ms. Shikha Sharma | Independent Director |
Mr. Sanjiv Mehta | Independent Director |
Mr. Arun M Kumar | Independent Director |
Dr. K P Krishnan | Independent Director |
Ms. Penny Wan | Independent Director |
Dr. Alpna Seth | Independent Director |
Dr. Reddy's Laboratories Forecast
Price Estimates
Dr. Reddy's Laboratories Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-07-27 | Quarterly Results & Stock Split | |
2024-05-07 | Audited Results & Final Dividend | |
2024-01-30 | Quarterly Results | |
2023-10-27 | Quarterly Results | |
2023-07-26 | Quarterly Results |
About Dr. Reddy's Laboratories
Dr. Reddy's Laboratories FAQs
What is Share Price of Dr. Reddy's Laboratories ?
Dr. Reddy's Laboratories share price is ₹6,631 As on 18 September, 2024 | 02:28
What is the Market Cap of Dr. Reddy's Laboratories ?
The Market Cap of Dr. Reddy's Laboratories is ₹110662.3 Cr As on 18 September, 2024 | 02:28
What is the P/E ratio of Dr. Reddy's Laboratories ?
The P/E ratio of Dr. Reddy's Laboratories is 19.9 As on 18 September, 2024 | 02:28
What is the PB ratio of Dr. Reddy's Laboratories ?
The PB ratio of Dr. Reddy's Laboratories is 3.9 As on 18 September, 2024 | 02:28
What is Dr Reddys Laboratories's stock price CAGR?
Dr Reddys Laboratories stock price CAGR for 10 Years stands at 12%, 5 Years at 8%, 3 Years at 20%, and 1 Year at -2%.
What is the ROE of Dr Reddys Laboratories?
The ROE of Dr Reddys Laboratories is 11%.
Is Dr Reddys Laboratories a good investment?
Dr Reddy's Laboratories has an operating revenue of Rs. 20,442.10 Cr. on a trailing 12-month basis. Annual revenue growth of 7% is good, Pre-tax margin of 15% is great. As per analysts rating in the last 6 months, the recommendation is to HOLD Dr Reddys Laboratories.
Who is the CEO of Dr Reddys Laboratories
Erez Israeli is the Chief Executive Officer (CEO) at Dr Reddy's Laboratories since 1 Aug 2019.
What is the Profit before tax of Dr. Reddys Laboratories Ltd stock?
Profit before tax of Dr. Reddys Laboratories Ltd stock for the quarter ended March 2022 is Rs 567 crores.
Q) How to buy Dr. Reddys Laboratories Ltd shares?
Ans - You can easily buy the shares of Dr. Reddys Laboratories Ltd, by registering at 5Paisa and by setting up a Demat Account in your name.
Q) What is the 52-week high and low price of shares of Dr Reddys Laboratories Ltd.
Ans – Dr Reddys Laboratories Ltd shares have a 52-week high of Rs 5,614.60 and a 52-week low of Rs 3,654.
Q) What is the Return of Equity on shares of Dr Reddys Laboratories Ltd for the past 1 year?
Ans – The Return on Equity on shares of Dr Reddys Laboratories Ltd is 11.8% for last year.
Q) What is the face value of a share of Dr Reddys Laboratories Ltd?
Ans – The face value of a share of Dr Reddys Laboratories Ltd. is INR 5 per share.